Previous studies showed that Src homology-2
tyrosine phosphatase (Shp2) is an important regulator of
body weight. In this study, we examined the impact of Shp2 deficiency specifically in
proopiomelanocortin (
POMC) neurons on metabolic and cardiovascular function and on chronic blood pressure (BP) and metabolic responses to
leptin. Mice with Shp2 deleted in
POMC neurons (Shp2/
Pomc-cre) and control mice (Shp2(flox/flox)) were implanted with telemetry probes and venous
catheters for measurement of mean arterial pressure (MAP) and
leptin infusion. After at least 5 days of stable control measurements, mice received
leptin infusion (2 μg·kg(-1)·day(-1) iv) for 7 days. Compared with Shp2(flox/flox) controls, Shp2/
Pomc-cre mice at 22 wk of age were slightly heavier (34 ± 1 vs. 31 ± 1 g) but consumed a similar amount of food (3.9 ± 0.3 vs. 3.8 ± 0.2 g/day).
Leptin infusion reduced food intake in Shp2(flox/flox) mice (2.6 ± 0.5 g) and Shp2/
Pomc-cre mice (3.2 ± 0.3 g). Despite decreasing food intake,
leptin infusion increased MAP in control mice, whereas no significant change in MAP was observed in Shp2/
Pomc-cre mice.
Leptin infusion also decreased plasma
glucose and
insulin levels in controls (12 ± 1 to 6 ± 1 μU/ml and 142 ± 12 to 81 ± 8 mg/100 ml) but not in Shp2/
Pomc-cre mice.
Leptin increased V̇o2 by 16 ± 2% in controls and 7 ± 1% in Shp2/
Pomc-cre mice. These results indicate that Shp2 signaling in
POMC neurons contributes to the long-term BP and
antidiabetic actions of
leptin and may play a modest role in normal regulation of
body weight.